Transitioning to a new platform

2024-11-06

The journal is transitioning to a new platform under a new publisher " Wolters Kluwer / Medknow".

Submissions will be turned off on this platform starting 11/9/2024. The new website will be available in early December 2024. We will send an email to all users with the new link. 

 

Appreciate all the support.

 

Editor-in-Chief

Awni Shahait, MD, FACS